Indian pharmaceutical tycoon Yusuf Hamied revolutionized AIDS treatment more than a decade ago by supplying cut-price drugs to the world’s poor — and now he wants to do the same for cancer.
Hamied, chairman of generic drugs giant Cipla, last month slashed the cost of three medicines to fight brain, kidney and lung cancer in India, making the drugs up to more than four times cheaper.
“I hope we’ll cut prices of many more cancer drugs,” he said, adding that he wants to supply the cheaper drugs to Africa and elsewhere. “Reducing the price of cancer drugs is a humanitarian move.”
Hamied, 76, was pilloried by Western drug giants 11 years ago when he broke their monopoly by offering to supply life-saving triple therapy AIDS drug cocktails for under US$1 a day — one-thirtieth the price set by the multinationals.
The firms branded him an intellectual property thief while he accused them of being “global serial killers” whose high prices were costing the lives of AIDS patients.
“What he did was path-breaking. It has been very important in saving lives, and what he is doing with cancer drugs is the same,” said Leena Menghaney, a lawyer with humanitarian group Medecins sans Frontieres (Doctors Without Borders).
In 1972, India made only the process for making drugs patentable, not the drugs themselves.
This meant firms could “reverse-engineer” or change methods used to make medicines and sell them at up to one-fiftieth of US prices.
The legislation gave a huge leg-up to India’s generics industry and gave the nation the nickname “the pharmacy to the Third World.”
However, in 2005, India brought its law in line with WTO rules recognizing 20-year patents, pushing up the prices of newly launched drugs.
Cipla, India’s fourth-largest pharmaceutical company by sales, has been pressing the government to allow widespread use of “compulsory licenses,” which are permitted under WTO rules.
The licenses allow companies to make existing life-saving drugs to sell in countries where they are otherwise priced out of reach.
India’s first such license was granted in March to Natco Pharma to produce a generic version of Bayer’s blockbuster kidney cancer drug Nexavar, cutting the price from 28,000 rupees (US$500) for a monthly dose to 6,840 rupees.
Ranjit Shahani, who heads the Organisation of Pharmaceutical Producers of India, says widespread compulsory licensing will jeopardize investment in innovative pharmaceuticals.
Bayer has said it will launch a legal challenge to the compulsory license, and global drugmakers have vowed to oppose the spread of such legislation.
Hamied denied that his latest move was simply an attempt to boost his share in the oncology drugs market, insisting business must be linked to “social responsibility.”
However, he said like any other business, his company, which has 23 cancer drugs, also wants sales.
“I owe it to my shareholders to be pragmatic,” he said.
Born in Lithuania to an Indian Muslim father and a Lithuanian Jewish mother, Hamied was two months old when his parents fled Europe in the 1930s under the threat of Nazi Germany.
He was raised in Mumbai and studied for a doctorate in chemistry at Cambridge University in Britain before joining Cipla, which was founded by his father.
“My father never forced me but chemistry was my best subject,” said Hamied, who became chairman of the company in 1989.
His bold step in offering cheap AIDS drugs turned out to be a smart business move.
Cipla is now the world’s largest AIDS antiretroviral drugs supplier and the publicly listed company is valued at nearly US$5 billion, while business magazine Forbes puts Hamied’s personal fortune at US$1.75 billion.
However, Hamied said poverty-racked India “can’t afford to divide people into those who can afford life-saving drugs and those who can’t.”
He believes the pharma giants should let emerging market drugmakers make copycat medicines in exchange for small royalties.
Some 95 percent of Western firms’ profits come from regulated developed markets like Japan, Europe and the US, so the pharmaceutical giants “really won’t lose out,” he added.
Even with the reduced price of generic drugs, such medicines are still beyond the reach of many of the world’s poorest, said Hamied, who confesses he has his eye on his legacy.
“I want it to be said when I leave this world that ‘he was not just a money-making machine,’” he said.
KINGPIN: Marset allegedly laundered the proceeds of his drug enterprise by purchasing and sponsoring professional soccer teams and even put himself in the starting lineups Notorious Latin American narco trafficker Sebastian Marset, who eluded police for years, was handed over to US authorities after his arrest on Friday in Bolivia. Marset, a Uruguayan national who was on the US most-wanted list, was passed to agents of the US Drug Enforcement Administration at Santa Cruz airport in Bolivia, then put on a US airplane, Bolivian state television showed. “The arrest and deportation were carried out pursuant to a court order issued by the US justice system,” Bolivian Minister of Government Marco Antonio Oviedo told reporters. The alleged kingpin was arrested in an upscale neighborhood of Santa
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
SCANDAL: Other images discovered earlier show Andrew bent over a female and lying across the laps of a number of women, while Mandelson is pictured in his underpants A photograph of former British prince Andrew and veteran politician Peter Mandelson sitting in bathrobes alongside late sex offender Jeffrey Epstein was unearthed on Friday in previously published documents. The image is believed to be the first known photograph of the two men with Epstein. They are currently engulfed in scandal in the UK over their ties to their mutual friend. The undated photograph, first reported by ITV News, shows King Charles III’s disgraced brother and former British ambassador to the US sitting barefoot outside on a wooden deck. They appear to have mugs with a US flag on them
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
RSS